accessibility menu, dialog, popup

UserName

CAS RN 1051375-16-6

CAS RN 1051375-16-6

IUPAC Name: —
Synonyms: —
Molecular Weight (g/mol): —
Molecular Formula: —
InChi Key: —
SMILES: —
Molecular Weight (g/mol) 
  • (11)
Quantity 
  • (1)
  • (2)
  • (1)
  • (1)
  • (2)
  • (1)
  • (2)
  • (1)
Percent Purity 
  • (3)
  • (7)
Color 
  • (7)
Grade 
  • (7)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (7)
  • (4)

special programs

  • (7)

Molecular Weight (g/mol)

  • (11)

Quantity

  • (1)
  • (2)
  • (1)
  • (1)
  • (2)
  • (1)
  • (2)
  • (1)

Percent Purity

  • (3)
  • (7)

Color

  • (7)

Grade

  • (7)

Physical Form

  • (7)
1 – 3 of 3 results
2

Dolutegravir, TRC

CAS: 1051375-16-6 Molecular Formula: C20 H19 F2 N3 O5 Molecular Weight (g/mol): 419.38 Synonym: 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-,(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide,Dolutegravir,GSK 1349572,S@fs:GSK1349572,Soltegravir,Tivicay,GSK 1349572B IUPAC Name: (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide SMILES: C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O

CAS 1051375-16-6
Molecular Weight (g/mol) 419.38
SMILES C[C@@H]1CCO[C@H]2CN3C=C(C(=O)NCc4ccc(F)cc4F)C(=O)C(=C3C(=O)N12)O
Synonym 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-,(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide,Dolutegravir,GSK 1349572,S@fs:GSK1349572,Soltegravir,Tivicay,GSK 1349572B
IUPAC Name (4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide
Molecular Formula C20 H19 F2 N3 O5
3

Dolutegravir, MedChemExpress

MedChemExpress Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM).

ENCOMPASS_PREFERRED
Molecular Weight (g/mol) 419.38
Color White
Physical Form Solid
Chemical Name or Material Dolutegravir
Grade Research
SMILES FC1=CC(F)=C(C=C1)CNC(C2=CN(C3=C(C2=O)O)C[C@@]([H])(N4C3=O)OCC[C@H]4C)=O
For Use With (Application) COVID-19-anti-virus
Percent Purity 98.76%
CAS 1051375-16-6
Solubility Information DMSO : 10 mg/mL (23.84 mM; Need ultrasonic and warming)
Health Hazard 1 H400∣H410
Synonym S/GSK1349572
Purity Grade Notes Research
Recommended Storage Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Shelf Life Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Molecular Formula C20H19F2N3O5
Formula Weight 419.38